Vision Rehab

Contact

Phone: 604-875-4267

Fax: 604-875-4239

Faculty

  • ML. Jackson – Clinical Associate Professor
  • S. Warner – Clinical Professor
  • S. Broome – Clinical Professor

Overview

  • The goal of the Vision Rehabilitation Clinic is to assist patients with low vision from any eye disease to effectively use all of their remaining vision. For many patients, magnification devices and specific strategies can allow them to read and continue to do other activities such as using a computer or cell phone.
  • Patients in our clinic may have low vision due to macular degeneration, diabetic retinopathy or glaucoma. Rehabilitation begins after patients have had diagnosis and evaluation by their eye doctor. Rehabilitation is part of the continuum of ophthalmic care, just as stroke rehabilitation or cardiac rehabilitation is part of the continuum of health care.

Our Approach

 Comprehensive vision rehabilitation care addresses five areas:

  • Reading rehabilitation
  • Activities of daily living
  • Patient Safety
  • Continued participation in events
  • Well-being, including adjustment to vision loss

We focus on the patient’s individual goals and on a detailed clinical evaluation of the patient’s vision, which includes

  • Visual acuity
  • Contrast sensitivity
  • Central visual field assessment using macular perimetry

 

 

Publications

Translational Vision Rehabilitation: From Eccentric Fixation to Reading Rehabilitation.

Mishra A, Jackson ML.

Semin Ophthalmol. 2016;31(1-2):169-77.

 

Clinically Meaningful Rehabilitation Outcomes of Low Vision Patients Served by Outpatient Clinical Centers.

Goldstein JE, Jackson ML, Fox SM, Deremeik JT, Massof RW; Low Vision Research Network Study Group.

JAMA Ophthalmol. 2015 Jul;133(7):762-9.

 

Comprehensive vision rehabilitation.

Gordon K, Bonfanti A, Pearson V, Markowitz SN, Jackson ML, Small L.

Can J Ophthalmol. 2015 Feb;50(1):85-6.

 

Feasibility of a web-based survey of hallucinations and assessment of visual function in patients with Parkinson’s disease.

Jackson ML, Bex PJ, Ellison JM, Wicks P, Wallis J.

Interact J Med Res. 2014 Jan 6;3(1):e1.

 

Characterization of field loss based on microperimetry is predictive of face recognition difficulties.

Wallis TS, Taylor CP, Wallis J, Jackson ML, Bex PJ.

Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):142-53. doi: 10.1167/iovs.13-12420.

 

Visual search with image modification in age-related macular degeneration.

Wiecek E, Jackson ML, Dakin SC, Bex P.

Invest Ophthalmol Vis Sci. 2012 Sep 25;53(10):6600-9.

 

Baseline traits of low vision patients served by private outpatient clinical centers in the United States.

Goldstein JE, Massof RW, Deremeik JT, Braudway S, Jackson ML, Kehler KB, Primo SA, Sunness JS; Low Vision Research Network Study Group.

Arch Ophthalmol. 2012 Aug;130(8):1028-37.

 

Geographic atrophy and visual function.

Mogk LG, Jackson ML, Dahl D.

Ophthalmology. 2012 Apr;119(4):885-885.e3; author reply 885. doi: 10.1016/j.ophtha.2011.09.052. No abstract available.

 

Visual function in the ‘oldest-old’ 1 year after comprehensive vision rehabilitation.

Jackson ML, Wallis J, Schoessow K, Drohan B, Williams K.

J Am Geriatr Soc. 2012 Jan;60(1):183-5.

 

 

Charles Bonnet Syndrome and glaucoma.

Jackson ML, Drohan B, Agrawal K, Rhee DJ.

Ophthalmology. 2011 May;118(5):1005-1005.e2.

 

Medicare coverage for vision assistive equipment.

Morse AR, Massof RW, Cole RG, Mogk LG, O’Hearn AM, Hsu YP, Faye EE, Wainapel SF, Jackson ML.

Arch Ophthalmol. 2010 Oct;128(10):1350-7. doi: 10.1001/archophthalmol.2010.228.

PMID: 20938006

Similar articles

Select item 1867570

 

Rehabilitation and intraocular telescopes.

Colenbrander A, Fletcher DC, Berlin AJ, Cole RJ, Christiansen RM, Faye E, Fontenot J, Glaser BM, Homer P, Jackson ML, Lawrence MG, Markowitz SN, Mogk L, Morgan R, Sabates N, Santos-Jimenez S, Shepherd J.

Ophthalmology. 2008 Aug;115(8):1437-8; author reply 1438. doi: 10.1016/j.ophtha.2008.04.021. No abstract available.

PMID: 18675705

Similar articles

Select item 16767192

 

Vision rehabilitation for Canadians with less than 20/40 acuity: the SmartSight model.

Jackson ML.

Can J Ophthalmol. 2006 Jun;41(3):355-61. Review.